Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.590
+0.040 (2.58%)
Dec 20, 2024, 4:00 PM EST - Market closed
Regulus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -41.63 | -30.04 | -28.32 | -27.81 | -15.73 | -18.59 | Upgrade
|
| Depreciation & Amortization | 0.34 | 0.23 | 0.12 | 0.46 | 0.47 | 0.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.22 | -0.16 | -0.19 | - | - | - | Upgrade
|
| Stock-Based Compensation | 6.31 | 2.8 | 2.18 | 2.92 | 2.61 | 2.29 | Upgrade
|
| Other Operating Activities | 0.07 | 0.14 | 0.13 | -0.62 | 0.15 | 2.13 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 0.5 | 0.64 | -1.12 | Upgrade
|
| Change in Inventory | -0.22 | - | - | 0.3 | 0.61 | 0.27 | Upgrade
|
| Change in Accounts Payable | 0.19 | 0.03 | -0.11 | -0.25 | -0.79 | -0.39 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -0.01 | -2.57 | Upgrade
|
| Change in Other Net Operating Assets | 0.21 | 0.23 | 0.66 | 0.36 | -0.5 | -2.77 | Upgrade
|
| Operating Cash Flow | -35.95 | -26.77 | -25.53 | -24.13 | -12.54 | -19.82 | Upgrade
|
| Capital Expenditures | -0.41 | -0.61 | -0.36 | -0.25 | - | -0.22 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | - | - | - | 0.32 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.01 | -0.02 | Upgrade
|
| Investment in Securities | -54.64 | 15.1 | -14.76 | - | - | - | Upgrade
|
| Investing Cash Flow | -55.05 | 14.49 | -15.12 | -0.25 | -0.01 | 0.07 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.66 | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.3 | - | -0.08 | -10.28 | -2.24 | Upgrade
|
| Net Debt Issued (Repaid) | -2.2 | -3.3 | - | -0.08 | -9.62 | -2.24 | Upgrade
|
| Issuance of Common Stock | 93.82 | 15.12 | 4.49 | 53.82 | 19.13 | 42.17 | Upgrade
|
| Other Financing Activities | -0.07 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 91.54 | 11.82 | 4.49 | 53.74 | 9.51 | 39.93 | Upgrade
|
| Net Cash Flow | 0.54 | -0.46 | -36.16 | 29.36 | -3.03 | 20.19 | Upgrade
|
| Free Cash Flow | -36.36 | -27.38 | -25.89 | -24.38 | -12.54 | -20.04 | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -125.28% | -293.35% | Upgrade
|
| Free Cash Flow Per Share | -0.81 | -1.44 | -1.70 | -2.84 | -3.58 | -11.61 | Upgrade
|
| Cash Interest Paid | 0.13 | 0.45 | 0.49 | 0.73 | 1.36 | 1.66 | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -21.58 | -16.93 | -14.35 | -15.81 | -6.13 | -13.55 | Upgrade
|
| Unlevered Free Cash Flow | -21.42 | -16.56 | -13.92 | -15.28 | -5 | -12.22 | Upgrade
|
| Change in Net Working Capital | -0.22 | -0.47 | -1.79 | 1.02 | -0.77 | 4.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.